Cargando…
Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection
INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829581/ https://www.ncbi.nlm.nih.gov/pubmed/29489059 http://dx.doi.org/10.1002/jia2.25082 |
_version_ | 1783302834365661184 |
---|---|
author | Laeyendecker, Oliver Konikoff, Jacob Morrison, Douglas E Brookmeyer, Ronald Wang, Jing Celum, Connie Morrison, Charles S Abdool Karim, Quarraisha Pettifor, Audrey E Eshleman, Susan H |
author_facet | Laeyendecker, Oliver Konikoff, Jacob Morrison, Douglas E Brookmeyer, Ronald Wang, Jing Celum, Connie Morrison, Charles S Abdool Karim, Quarraisha Pettifor, Audrey E Eshleman, Susan H |
author_sort | Laeyendecker, Oliver |
collection | PubMed |
description | INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known duration of infection (2442 samples from 278 adults; 0.1 to 9.9 years after seroconversion). MAAs included 1‐4 of the following assays: Limiting Antigen Avidity assay (LAg‐Avidity), BioRad‐Avidity assay, CD4 cell count and viral load (VL). We evaluated 23,400 MAAs with different assays and assay cutoffs. We identified the MAA with the largest mean window period, where the upper 95% confidence interval (CI) of the shadow was <1 year. This MAA was compared to the LAg‐Avidity and BioRad‐Avidity assays alone, a widely used LAg algorithm (LAg‐Avidity <1.5 OD‐n + VL >1000 copies/mL), and two MAAs previously optimized for subtype B settings. We compared these cross‐sectional incidence estimates to observed incidence in an independent longitudinal cohort. RESULTS: The optimal MAA was LAg‐Avidity <2.8 OD‐n + BioRad‐Avidity <95% + VL >400 copies/mL. This MAA had a mean window period of 248 days (95% CI: 218, 284), a shadow of 306 days (95% CI: 255, 359), and provided the most accurate and precise incidence estimate for the independent cohort. The widely used LAg algorithm had a shorter mean window period (142 days, 95% CI: 118, 167), a longer shadow (410 days, 95% CI; 318, 491), and a less accurate and precise incidence estimate for the independent cohort. CONCLUSIONS: An optimal MAA was identified for cross‐sectional HIV incidence in subtype C settings. The performance of this MAA is superior to a testing algorithm currently used for global HIV surveillance. |
format | Online Article Text |
id | pubmed-5829581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58295812018-03-01 Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection Laeyendecker, Oliver Konikoff, Jacob Morrison, Douglas E Brookmeyer, Ronald Wang, Jing Celum, Connie Morrison, Charles S Abdool Karim, Quarraisha Pettifor, Audrey E Eshleman, Susan H J Int AIDS Soc Research Articles INTRODUCTION: Cross‐sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi‐assay algorithms (MAAs) for incidence estimation in subtype C settings. METHODS: We analysed samples from individuals with subtype C infection with known duration of infection (2442 samples from 278 adults; 0.1 to 9.9 years after seroconversion). MAAs included 1‐4 of the following assays: Limiting Antigen Avidity assay (LAg‐Avidity), BioRad‐Avidity assay, CD4 cell count and viral load (VL). We evaluated 23,400 MAAs with different assays and assay cutoffs. We identified the MAA with the largest mean window period, where the upper 95% confidence interval (CI) of the shadow was <1 year. This MAA was compared to the LAg‐Avidity and BioRad‐Avidity assays alone, a widely used LAg algorithm (LAg‐Avidity <1.5 OD‐n + VL >1000 copies/mL), and two MAAs previously optimized for subtype B settings. We compared these cross‐sectional incidence estimates to observed incidence in an independent longitudinal cohort. RESULTS: The optimal MAA was LAg‐Avidity <2.8 OD‐n + BioRad‐Avidity <95% + VL >400 copies/mL. This MAA had a mean window period of 248 days (95% CI: 218, 284), a shadow of 306 days (95% CI: 255, 359), and provided the most accurate and precise incidence estimate for the independent cohort. The widely used LAg algorithm had a shorter mean window period (142 days, 95% CI: 118, 167), a longer shadow (410 days, 95% CI; 318, 491), and a less accurate and precise incidence estimate for the independent cohort. CONCLUSIONS: An optimal MAA was identified for cross‐sectional HIV incidence in subtype C settings. The performance of this MAA is superior to a testing algorithm currently used for global HIV surveillance. John Wiley and Sons Inc. 2018-02-28 /pmc/articles/PMC5829581/ /pubmed/29489059 http://dx.doi.org/10.1002/jia2.25082 Text en © 2018 The Authors. Journal of the International AIDS Society published by John Wiley & sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Laeyendecker, Oliver Konikoff, Jacob Morrison, Douglas E Brookmeyer, Ronald Wang, Jing Celum, Connie Morrison, Charles S Abdool Karim, Quarraisha Pettifor, Audrey E Eshleman, Susan H Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title | Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title_full | Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title_fullStr | Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title_full_unstemmed | Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title_short | Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection |
title_sort | identification and validation of a multi‐assay algorithm for cross‐sectional hiv incidence estimation in populations with subtype c infection |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829581/ https://www.ncbi.nlm.nih.gov/pubmed/29489059 http://dx.doi.org/10.1002/jia2.25082 |
work_keys_str_mv | AT laeyendeckeroliver identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT konikoffjacob identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT morrisondouglase identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT brookmeyerronald identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT wangjing identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT celumconnie identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT morrisoncharless identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT abdoolkarimquarraisha identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT pettiforaudreye identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection AT eshlemansusanh identificationandvalidationofamultiassayalgorithmforcrosssectionalhivincidenceestimationinpopulationswithsubtypecinfection |